Patient engagement is advocated widely across health systems worldwide, but what we mean by “engagement” differs greatly depending on context. Consider two scenarios: a patient working with her doctor to decide on a cancer treatment, and a patient representative helping design a cancer research trial. Both fall under “patient engagement,” yet they involve distinctly different roles and impacts. We should start distinguishing primary from secondary engagement to clarify discourse and improve evaluation and implementation.